A critical breakthrough in cancer study is emerging with the use of VHH fragments to reactivate mutated p53. This crucial tumor inhibitor protein is frequently inactivated in several types of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research